Published in Am J Dis Child on January 01, 1984
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother (1993) 1.34
Isolation of bacteriophage MX4, a generalized transducing phage for Myxococcus xanthus. J Mol Biol (1978) 6.76
Field Evaluation of a Human Anthrax Vaccine. Am J Public Health Nations Health (1962) 5.44
Regulation of development in Myxococcus xanthus: effect of 3':5'-cyclic AMP, ADP, and nutrition. Proc Natl Acad Sci U S A (1975) 4.61
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Human cytomegalovirus stimulates host cell RNA synthesis. J Virol (1975) 2.41
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood. Am J Epidemiol (1968) 2.36
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science (1984) 2.34
Idiopathic arterial calcification of infancy: prenatal and postnatal effects of therapy in an infant. J Pediatr (1992) 2.21
Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol (1975) 2.21
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics (2001) 2.10
A clinical model for diagnosis of urinary tract infection in young women. Arch Intern Med (1989) 2.07
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Candidate cytomegalovirus strain for human vaccination. Infect Immun (1975) 1.99
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. Clin Endocrinol (Oxf) (1998) 1.99
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis (1988) 1.97
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis (1995) 1.92
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Minimal infective dose of attenuated poliovirus for man. Am J Public Health Nations Health (1967) 1.89
Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child (1983) 1.86
Rapid detection of human cytomegalovirus in the urine of humans. J Infect Dis (1985) 1.85
Surface colonization with coagulase-negative staphylococci in premature neonates. J Pediatr (1989) 1.84
Physical characterization of bacteriophage MX4, a generalized transducing phage for Myxococcus xanthus. J Mol Biol (1978) 1.83
Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet (1984) 1.81
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Optochin resistance in Streptococcus pneumoniae: mechanism, significance, and clinical implications. J Infect Dis (2001) 1.78
Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc Soc Exp Biol Med (1978) 1.78
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods (1983) 1.76
Age-specific risks of varicella complications. Pediatrics (1981) 1.76
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Distinguishing sepsis from blood culture contamination in young infants with blood cultures growing coagulase-negative staphylococci. Pediatrics (1990) 1.73
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. Br Med J (1965) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis (1976) 1.68
Stimulation of macromolecular synethesis in guinea pig cells by human CMV. Proc Soc Exp Biol Med (1975) 1.67
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics (1982) 1.64
Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis (1999) 1.64
The assay of milk-ejecting activity in the lactating rat. Br J Pharmacol Chemother (1967) 1.63
Human cell culture rabies vaccine. Antibody response in man. JAMA (1973) 1.63
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis (1991) 1.62
Vulvovaginitis in premenarcheal girls: clinical features and diagnostic evaluation. Pediatrics (1982) 1.62
Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine (1991) 1.57
Nonproductive infection of guinea pig cells with human cytomegalovirus. J Virol (1973) 1.56
A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion. Am J Epidemiol (1967) 1.56
Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child (1966) 1.56
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics (1985) 1.50
Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (1997) 1.50
Outbreak of cryptosporidiosis in a day-care center. Pediatrics (1986) 1.44
Responding to The River. Science (1999) 1.42
Evaluation of Detect-A-Strep and the Culturette Ten-Minute Strep ID kits for detection of group A streptococcal antigen in oropharyngeal swabs from children. J Clin Microbiol (1985) 1.42
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis (1996) 1.42
Varicella: complications and costs. Pediatrics (1986) 1.41
Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med (1989) 1.40
Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysis. J Clin Microbiol (1985) 1.40
Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39
Recurrent ascites in an infant with perinatally acquired cytomegalovirus infection. Eur J Pediatr (1989) 1.39
Congenital rubella cataracts. Surgical results and virus recovery from intraocular tissue. Arch Ophthalmol (1967) 1.38
Haemophilus influenzae type b endocarditis and meningitis in a previously healthy child. Pediatr Infect Dis J (1992) 1.38
Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis (1979) 1.36
Cryptosporidiosis in a day-care center. N Engl J Med (1984) 1.35
The characterization of IgG receptor induced by human cytomegalovirus. Proc Soc Exp Biol Med (1977) 1.33
Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus. Am J Dis Child (1965) 1.32
Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression. J Pediatr (1994) 1.30
Precipitin responses to rubella vaccine RA 27-3. J Infect Dis (1971) 1.28
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation (1985) 1.26
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26
Assessment of susceptibility to measles and rubella. JAMA (1982) 1.26
Rabies vaccine prepared in human cell cultures: progress and perspectives. Rev Infect Dis (1980) 1.26
Universal immunization to interrupt rubella. Rev Infect Dis (1985) 1.25
Use of Native American healers among Native American patients in an urban Native American health center. Arch Fam Med (1998) 1.24
A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J (1985) 1.24
Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens. Infect Immun (1980) 1.24
Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis. Nature (1976) 1.24
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. Am J Dis Child (1969) 1.23
Immunization schedules for the new human diploid cell vaccine against rabies. Am J Epidemiol (1976) 1.23
Excitation of phasically firing hypothalamic supraoptic neurones by carotid occlusion in rats. J Physiol (1976) 1.22
Feeding of school children in a London borough. Br Med J (1977) 1.21
The opportunity and obligation to eliminate rubella from the United States. JAMA (1984) 1.20
Induction of DNA Polymerase in WI-38 and guinea pig cells infected with human cytomegalovirus (HCMV). Virology (1976) 1.20
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines. J Infect Dis (1996) 1.20